{"transactions":[{"id":2735695,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":139938,"kind":"person","name":"WHITESIDES GEORGE M","position":1,"cik":"0001233438","reported_name":"WHITESIDES GEORGE M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2021-04-29T18:14:28.000Z","date":"2021-04-27","kind":"grant","acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the Company's shareholders provided the optionee remains in continuous service on such date."}],"balance_after":6000,"derivative":{"exercise_price":20.35,"expiration_date":"2031-04-26","underlying":"Ordinary Shares","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001179110-21-004703","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1233438/000117911021004703/edgar.xml","form_type":"4"}},{"id":2735694,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":139938,"kind":"person","name":"WHITESIDES GEORGE M","position":1,"cik":"0001233438","reported_name":"WHITESIDES GEORGE M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2021-04-29T18:14:28.000Z","date":"2021-04-27","kind":"grant","acquired":true,"shares":9828,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":9828,"source":{"system":"sec-edgar","filing":"0001179110-21-004703","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1233438/000117911021004703/edgar.xml","form_type":"4"}},{"id":3159291,"issuer":{"id":46837,"kind":"organization","name":"Lyra Therapeutics, Inc.","symbol":"LYRA"},"owners":[{"id":139938,"kind":"person","name":"WHITESIDES GEORGE M","position":1,"cik":"0001233438","reported_name":"WHITESIDES GEORGE M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A-1/C Convertible Preferred Stock","published_at":"2020-05-06T19:34:57.000Z","date":"2020-05-05","kind":"exercise","acquired":false,"shares":67672,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The preferred stock is convertible at any time, at the holder's election and has no expiration date. Each share of preferred stock was automatically converted into 0.0289998 shares of common stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The preferred stock is convertible at any time, at the holder's election and has no expiration date. Each share of preferred stock was automatically converted into 0.0289998 shares of common stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The preferred stock is convertible at any time, at the holder's election and has no expiration date. Each share of preferred stock was automatically converted into 0.0289998 shares of common stock upon the closing of the Issuer's initial public offering."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1962},"source":{"system":"sec-edgar","filing":"0000899243-20-012177","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1233438/000089924320012177/doc4.xml","form_type":"4"}},{"id":3159290,"issuer":{"id":46837,"kind":"organization","name":"Lyra Therapeutics, Inc.","symbol":"LYRA"},"owners":[{"id":139938,"kind":"person","name":"WHITESIDES GEORGE M","position":1,"cik":"0001233438","reported_name":"WHITESIDES GEORGE M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A-1/B Convertible Preferred Stock","published_at":"2020-05-06T19:34:57.000Z","date":"2020-05-05","kind":"exercise","acquired":false,"shares":55991,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The preferred stock is convertible at any time, at the holder's election and has no expiration date. Each share of preferred stock was automatically converted into 0.0289998 shares of common stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The preferred stock is convertible at any time, at the holder's election and has no expiration date. Each share of preferred stock was automatically converted into 0.0289998 shares of common stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The preferred stock is convertible at any time, at the holder's election and has no expiration date. Each share of preferred stock was automatically converted into 0.0289998 shares of common stock upon the closing of the Issuer's initial public offering."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1623},"source":{"system":"sec-edgar","filing":"0000899243-20-012177","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1233438/000089924320012177/doc4.xml","form_type":"4"}},{"id":3159289,"issuer":{"id":46837,"kind":"organization","name":"Lyra Therapeutics, Inc.","symbol":"LYRA"},"owners":[{"id":139938,"kind":"person","name":"WHITESIDES GEORGE M","position":1,"cik":"0001233438","reported_name":"WHITESIDES GEORGE M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A-1/A Convertible Preferred Stock","published_at":"2020-05-06T19:34:57.000Z","date":"2020-05-05","kind":"exercise","acquired":false,"shares":97216,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The preferred stock is convertible at any time, at the holder's election and has no expiration date. Each share of preferred stock was automatically converted into 0.0289998 shares of common stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The preferred stock is convertible at any time, at the holder's election and has no expiration date. Each share of preferred stock was automatically converted into 0.0289998 shares of common stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The preferred stock is convertible at any time, at the holder's election and has no expiration date. Each share of preferred stock was automatically converted into 0.0289998 shares of common stock upon the closing of the Issuer's initial public offering."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2819},"source":{"system":"sec-edgar","filing":"0000899243-20-012177","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1233438/000089924320012177/doc4.xml","form_type":"4"}},{"id":3159288,"issuer":{"id":46837,"kind":"organization","name":"Lyra Therapeutics, Inc.","symbol":"LYRA"},"owners":[{"id":139938,"kind":"person","name":"WHITESIDES GEORGE M","position":1,"cik":"0001233438","reported_name":"WHITESIDES GEORGE M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-06T19:34:57.000Z","date":"2020-05-05","kind":"exercise","acquired":true,"shares":6404,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":55064,"source":{"system":"sec-edgar","filing":"0000899243-20-012177","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1233438/000089924320012177/doc4.xml","form_type":"4"}},{"id":3165345,"issuer":{"id":46837,"kind":"organization","name":"Lyra Therapeutics, Inc.","symbol":"LYRA"},"owners":[{"id":139938,"kind":"person","name":"WHITESIDES GEORGE M","position":1,"cik":"0001233438","reported_name":"WHITESIDES GEORGE M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2020-05-01T18:35:07.000Z","date":"2020-04-30","kind":"grant","acquired":true,"shares":14500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests and becomes exercisable in 36 equal monthly installments occurring on the completion of each successive month of the Reporting Person's service to the Issuer following April 30, 2020."}],"balance_after":14500,"derivative":{"exercise_price":16,"expiration_date":"2030-04-29","underlying":"Common Stock","underlying_shares":14500},"source":{"system":"sec-edgar","filing":"0000899243-20-011746","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1233438/000089924320011746/doc4.xml","form_type":"4"}},{"id":3165344,"issuer":{"id":46837,"kind":"organization","name":"Lyra Therapeutics, Inc.","symbol":"LYRA"},"owners":[{"id":139938,"kind":"person","name":"WHITESIDES GEORGE M","position":1,"cik":"0001233438","reported_name":"WHITESIDES GEORGE M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-01T18:35:07.000Z","date":"2020-05-01","kind":"grant","acquired":true,"shares":19661,"price":16,"value":314576.0,"ownership":{"direct":true},"balance_after":48660,"source":{"system":"sec-edgar","filing":"0000899243-20-011746","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1233438/000089924320011746/doc4.xml","form_type":"4"}},{"id":3166375,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":139938,"kind":"person","name":"WHITESIDES GEORGE M","position":1,"cik":"0001233438","reported_name":"WHITESIDES GEORGE M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2020-04-30T21:14:18.000Z","date":"2020-04-28","kind":"grant","acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the Company's shareholders provided the optionee remains in continuous service on such date."}],"balance_after":6000,"derivative":{"exercise_price":30.14,"expiration_date":"2030-04-27","underlying":"Ordinary Shares","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001179110-20-005323","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1233438/000117911020005323/edgar.xml","form_type":"4"}},{"id":3166374,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":139938,"kind":"person","name":"WHITESIDES GEORGE M","position":1,"cik":"0001233438","reported_name":"WHITESIDES GEORGE M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2020-04-30T21:14:18.000Z","date":"2020-04-28","kind":"grant","acquired":true,"shares":6635,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":6635,"source":{"system":"sec-edgar","filing":"0001179110-20-005323","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1233438/000117911020005323/edgar.xml","form_type":"4"}},{"id":3542150,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":139938,"kind":"person","name":"WHITESIDES GEORGE M","position":1,"cik":"0001233438","reported_name":"WHITESIDES GEORGE M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2019-05-02T18:34:23.000Z","date":"2019-04-30","kind":"grant","acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the Company's shareholders provided the optionee remains in continuous service on such date."}],"balance_after":6000,"derivative":{"exercise_price":23.85,"expiration_date":"2029-04-29","underlying":"Ordinary Shares","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001179110-19-005469","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1233438/000117911019005469/edgar.xml","form_type":"4"}},{"id":3542149,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":139938,"kind":"person","name":"WHITESIDES GEORGE M","position":1,"cik":"0001233438","reported_name":"WHITESIDES GEORGE M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2019-05-02T18:34:23.000Z","date":"2019-01-02","kind":"gift","acquired":false,"shares":21012,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Family Trust"},"balance_after":27650,"source":{"system":"sec-edgar","filing":"0001179110-19-005469","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1233438/000117911019005469/edgar.xml","form_type":"4"}},{"id":3542148,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":139938,"kind":"person","name":"WHITESIDES GEORGE M","position":1,"cik":"0001233438","reported_name":"WHITESIDES GEORGE M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2019-05-02T18:34:23.000Z","date":"2019-04-30","kind":"grant","acquired":true,"shares":8385,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":200963,"source":{"system":"sec-edgar","filing":"0001179110-19-005469","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1233438/000117911019005469/edgar.xml","form_type":"4"}},{"id":3947129,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":139938,"kind":"person","name":"WHITESIDES GEORGE M","position":1,"cik":"0001233438","reported_name":"WHITESIDES GEORGE M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2018-05-03T18:20:00.000Z","date":"2018-05-01","kind":"grant","acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the Company's shareholders provided the optionee remains in continuous service on such date."}],"balance_after":6000,"derivative":{"exercise_price":24.43,"expiration_date":"2028-04-30","underlying":"Ordinary Shares","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001179110-18-006196","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1233438/000117911018006196/edgar.xml","form_type":"4"}},{"id":3947128,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":139938,"kind":"person","name":"WHITESIDES GEORGE M","position":1,"cik":"0001233438","reported_name":"WHITESIDES GEORGE M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2018-05-03T18:20:00.000Z","date":"2018-05-01","kind":"grant","acquired":true,"shares":8186,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":192578,"source":{"system":"sec-edgar","filing":"0001179110-18-006196","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1233438/000117911018006196/edgar.xml","form_type":"4"}},{"id":4235141,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":139938,"kind":"person","name":"WHITESIDES GEORGE M","position":1,"cik":"0001233438","reported_name":"WHITESIDES GEORGE M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2017-08-14T20:00:33.000Z","date":"2017-08-11","kind":"purchase","acquired":true,"shares":4000,"price":24.691,"value":98764.0,"ownership":{"direct":false,"nature":"By Trust"},"balance_after":4000,"source":{"system":"sec-edgar","filing":"0001179110-17-011479","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1233438/000117911017011479/edgar.xml","form_type":"4"}},{"id":4313332,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":139938,"kind":"person","name":"WHITESIDES GEORGE M","position":1,"cik":"0001233438","reported_name":"WHITESIDES GEORGE M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2017-05-18T18:05:30.000Z","date":"2017-05-17","kind":"grant","acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":184392,"source":{"system":"sec-edgar","filing":"0001179110-17-007546","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1233438/000117911017007546/edgar.xml","form_type":"4"}}]}